MONDAY, July 17, 2023 (HealthDay News) — A new study offers the first-ever county-level estimates of Alzheimer’s disease in the United States. It shows that the East and Southeast have the highest prevalence of Alzheimer’s dementia, which researchers said may owe in part to the higher percentages of older people,Continue Reading

MONDAY, July 17, 2023 (HealthDay News) — Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing disease. In research published online Monday in the Journal of the American Medical Association and presented simultaneously at the Alzheimer’sContinue Reading

MONDAY, July 17, 2023 (HealthDay News) — Two new studies using CRISPR gene editing offer potential new treatments for Alzheimer’s disease. “A pipeline of potential new treatments offers hope for the Alzheimer’s and dementia community,” said Maria Carrillo, chief science officer for the Alzheimer’s Association. “The progress and approvals we’veContinue Reading

TUESDAY, July 11, 2023 (HealthDay News) — As extreme heat continues to blanket numerous parts of the United States, Americans with dementia may be particularly challenged. “Triple-digit temperatures and heat indexes are especially dangerous for someone with a dementia-related illness such as Alzheimer’s disease, because the effects of dementia canContinue Reading

THURSDAY, July 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug.Continue Reading